Additionally, SND1 is frequently overexpressed in multiple types of cancer, such as colon [10, 11], prostate [12], breast [13, 14], bladder [15] and hepatocellular carcinomas [16] and exhibits cytoprotective and oncogenic activity by promoting the proliferation of tumor cells [17–19]. Here, SND1 is linked to cancer.